3Suh O, Mettlin C, Petrelli NJ. Aspirin use, cancer, and polypsof the large bowel[J]. Cancer, 1993, 72(4):1171 - 1177.
4Khuder SA, Mutgi AB. Breast cancer and NSAID use: a meta-analysis[J]. Br J Cancer, 2001, 84 (9): 1188 -1192.
5Di Sario JA, Alberts DS, Tietze CC, et al. Sulindac induces regression and prevents progression of sporadic colorectal adenomas[J]. Gastroenterology, 1997, 112(6):1284- 1290.
6Van SR, Budd GT, Kresty R, et al. Effect of sulindac sulfone on proliferation, apoptosis and polyps in a clinical trial in FAP with rectal polyps[J]. Gastroenterology, 1998, 114(4) :2881 - 2885.
7Barnes C J, Lee M. Chemoprevention of spontaneous intestinal adenomas in the adenomatous polyposis coli Min mouse model with aspirin[J]. Gastroenterology, 1998, 114(5):873 - 877.
8Boolbol SK, Dannenberg A J, Chadburn AR, et al. Cyclooxygenase-2 overexpression and tumor formation are blocked by sulindac in a murine model of familial adenomatous polyposis[J]. Cancer Res, 1996, 56(11):2556 -2560.
9Yao RS, Rioux N, Andre C, et al. Nonsteroids antiinflammatory agents- physiological effect; lung tumors chemotherapy[J]. Exp Lung Res, 2000, 26 (8): 325 -330.
10Kawamori T, Rao CV, Seibert K, et al. Chemopreventive activity of celecoxib, a specific cyclooxygenase-2 inhibitor,against colon carcinogenesis [J]. Cancer Res, 1998, 58(3) :409 - 412.
